Minerva Biotechnologies is a cutting-edge biotech company based in Waltham, MA, specializing in cancer and stem cell therapeutics. With a focus on developing cancer immunotherapies targeting 80% of solid tumors and preventing cancer metastasis, Minerva Biotechnologies is at the forefront of innovative research and development in the field.
Driven by their commitment to exploring the space between cancers and stem cells, Minerva Biotechnologies is revolutionizing cancer therapeutics with their CAR T therapeutics that effectively attack MUC1 positive solid tumors, representing a significant breakthrough in the treatment of various cancers. Additionally, their stem cell discoveries enable the utilization of regenerative medicine in a wide range of diseases, while their AlphaSTEM technology enhances iPSC generation, cell expansion, and differentiation efficiency.
Generated from the website